FcεRI-dependent tyrosine phosphorylation in human mast cells:: Comparative effects of tyrosine kinase and tyrosine phosphatase inhibitors.

被引：0
|
作者：
Tkaczyk, C [1 ]
Metcalfe, DD [1 ]
Gilfillan, AM [1 ]
机构：
[1] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA
来源：
FASEB JOURNAL | 2000年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1245 / A1245
页数：1
相关论文
共 50 条
  • [21] Synthesis of PDGF receptor tyrosine kinase inhibitors.
    He, W
    Myers, MR
    Spada, AP
    Hanney, BA
    Setzer, N
    Maguire, M
    Mailliet, P
    Gontier, S
    Guegen, JC
    Cans, P
    Orton, E
    Cheve, M
    Kubiak, GG
    Shah, HC
    O'brien, MK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U128 - U128
  • [22] Chronic myelogenous leukemic and tyrosine kinase inhibitors.
    Mahon, FX
    REVUE DE MEDECINE INTERNE, 2001, 22 (09): : 894 - 899
  • [23] QSAR study on some tyrosine kinase inhibitors.
    Kurup, A
    Garg, R
    Hansch, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U414 - U414
  • [24] FceRI-Aggregation initiates both tyrosine phosphorylation and tyrosine dephosphorylation in human mast cells
    Tkaczyk, C
    Tuan, A
    Kirshenbaum, A
    Metcalfe, DD
    Gilfillan, AM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S87 - S87
  • [25] The Role Played by Autophagy in FcεRI-Dependent Activation of Mast Cells
    Pavlyuchenkova, Anastasia N.
    Smirnov, Maxim S.
    Chernyak, Boris V.
    Chelombitko, Maria A.
    CELLS, 2024, 13 (08)
  • [26] Reconstitution of regulated phosphorylation of FcεRI by a lipid raft-excluded protein-tyrosine phosphatase
    Young, RM
    Zheng, XM
    Holowka, D
    Baird, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (02) : 1230 - 1235
  • [27] Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells
    Gleixner, Karoline V.
    Rebuzzi, Laura
    Mayerhofer, Matthias
    Gruze, Alexander
    Hadzijusufovic, Emir
    Sonneck, Karoline
    Vales, Anja
    Kneidinger, Michael
    Samorapoompichit, Puchit
    Thaiwong, Tuddow
    Pickl, Winfried F.
    Yuzbasiyan-Gurkan, Vilma
    Sillaber, Christian
    Willmann, Michael
    Valent, Peter
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (10) : 1510 - 1521
  • [28] PDGF stimulates tyrosine phosphorylation of JAK 1 protein tyrosine kinase in human mesangial cells
    Choudhury, GG
    Marra, F
    Kiyomoto, H
    Abboud, HE
    KIDNEY INTERNATIONAL, 1996, 49 (01) : 19 - 25
  • [29] Screening practices for late effects in pediatric patients on tyrosine kinase inhibitors.
    Smith, Stephanie M.
    Sabnis, Himalee S.
    Lewis, Rebecca Williamson
    Effinger, Karen Elizabeth
    Bergsagel, Daniel John
    Patterson, Briana
    Mertens, Ann C.
    Sakamoto, Kathleen
    Schapira, Lidia
    Castellino, Sharon M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Olanzapine for managing side effects from tyrosine-kinase inhibitors.
    Koch, Regina
    Muniz, Miguel
    Peskey, Candy
    Jatoi, Aminah
    Ruddy, Kathryn Jean
    Orme, Jacob
    Pagliaro, Lance C.
    Quevedo, Fernando
    Costello, Brian Addis
    Megan, Spychalla
    Heath, Elisabeth I.
    Zakharia, Yousef
    Singh, Parminder
    Riaz, Irbaz Bin
    Cathcart-Rake, Elizabeth Jane
    D'Andre, Stacy D.
    Loprinzi, Charles L.
    Childs, Daniel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : 524 - 524
12345